I have heard frustration from oncologic practices regarding radiology reports. Here are a few ways we can help improve radiologic-oncology care.
Oncologic imaging has exploded in many groups over recent years. Many protocols require repeated, frequent imaging and therefore management depends importantly on radiologic reporting.
On the oncologic side, a tremendous amount of information is provided to care co-coordinators and oncologists for management. This includes not only radiology information, but increased lab data and ever-more specific pathology data. Care also increasingly depends on integration of this information with radiological findings, accurate sub-typing of cancer and concordance between radiology lab values and radiology pathology results.
In some cases I have heard frustration from oncologic practices regarding radiology reports. Sometimes this is justified, sometimes not. But it points out a few things to us as we improve radiologic-oncology care:
1. Oncologists need consistency of reporting for individual patients. Some radiologists resist having uniform reporting, as it may not fit their style. Where possible, the practice would serve its referring physicians and patients well to look for a consensus on reporting. This can be developed in discussion with the leadership of referring oncologic providers. At a minimum, it is a good idea to open a dialogue with the oncologists as to what information should be targeted in oncologic reports for them. The structure of the report may need to be different than a classical model, perhaps with summary relevant oncologic information separately identified.
2. The most specific diagnosis yields the best treatment, and relies on consistency or concordance of radiologic and pathologic data. We’ve all been at conferences where the pathologic diagnosis suggests something that is not likely by imaging.
Today, there is no excuse for either radiologists or pathologists to work in the dark, and independent of one another. The low tech solution is multi-disciplinary conferences, and your practice should actively participate in those. You may want to identify a handful of oncologic radiologists to offer consistency for those. The phone is a low tech tool too. Don’t resist picking it up and consulting with your pathology colleagues. That process should be formalized and mandated, and occur as real-time as possible.
The high-tech methods are novel IT systems that allow for summary display of radiology and pathology information. Ask your IT system administrator if that is available to you. If so, it is a powerful tool. Merging data and unstructured text into a summary simplifies its interpretation greatly.
3. The processes of radiologic, laboratory and pathologic diagnosis need to be uniform too. In fact, this process should be formalized so that there is always communication between these disciplines, there is standard method used and work flow is coordinated. Sit down with the lab and pathologist and make sure that there is a consistent method for acquiring pathologic material and processing. Talk with your group and seek to have uniformity of methods. Wherever the process can be coordinated and made more uniform, you should seek to do so.
4. When there are problems and delays, patients can’t be managed. Have a QA process to analyze all turn-around-time delays. This means that instead of looking only at your report TAT, you should look at the system TAT for things that are multi-disciplinary (biopsies), including all modalities if appropriate.
Ultimately, good oncologic radiology care will rely on consistency, real-time collaboration across disciplines and rigor of process
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.